Skip main navigation

Protein biomarker discovery: proteomics application in translational research

Protein biomarker discovery: proteomics application in translational research
In this section, we are talking about protein biomarker discovery. I am Dr. Cheng. This topic is an issue about proteomic application in translational medicine. Protein biomarker discovery is integrate many components of translational
medicine including: clinical on Med, bench side, and personal medicine. There are two major techniques are involved in protein biomarker discovery by proteomics. First, two dimensional electrophoresis was applied to identify the differentially expressed proteins between normal and deceased subjects. Then, MALDI-TOF mass spectrometry were applied to identify differentially expressed proteins in cancer specimens and summarize the identify the protein and their gene length. In this section, using lung cancer for example to elucidate, lung cancer biomarkers development procedure. Normal lung cell and lung cancer adenocarcinoma cells are used to identify differentially expressed proteins extract cell membrane proteins (then running two- dimensional electrophoresis to separate individual proteins spot in gel.
Mass spectrum is applied to identify the differentially expressed proteins. In this example, between these two groups, 8 clusters of protein spots were significantly different in protein level. Capture the differential express protein to identify by MALDI-TOF Mass spectrum analysis. Then evaluate the functional activities of each protein. After evaluate the functional activities of differential expressed proteins according selected candidate protein to develop detection tool. In this experiment, Galectin-1 significance increase in cancer cell and affect the cell activity. Selecting Galectin-1 as a lung cancer protein biomarker candidate clone and produce galectin-1 protein to develop antibody for diagnosis and targeting use.
Monoclonal antibody production is a common use tool to create detection antibody. First, we need to immunize mice with candidate protein. When mice plasma, Anti-Galectin-1 antibody titer are increased, sacrifice the mice and harvest the spleen cell then fusions the spleen cell with myeloma cell. The fused cell named hybridoma. Hybridoma will exist on limited population and antibody production activity. Screen monoclonal antibody by Galectin-1 coded ELISA plate. In this step, hybridoma culture medium are used for test. After screening, developed monoclonal antibodies could be used to detect disease protein biomarkers.
This biomarker can be further application for clinical diagnosis or targeting serum to be used. Thank you for your attention.

Protein biomarkers discovery integrates many components of translational medicine.

In this video, Prof. Cheng will introduce two major proteomics techniques for discovering protein biomarkers:

  • 2-D electrophoresis
  • MALDI-TOF Mass Spectrometry

Prof. Tsai-Mu Cheng

This article is from the free online

Introduction to Translational Research: Connecting Scientists and Medical Doctors

Created by
FutureLearn - Learning For Life

Our purpose is to transform access to education.

We offer a diverse selection of courses from leading universities and cultural institutions from around the world. These are delivered one step at a time, and are accessible on mobile, tablet and desktop, so you can fit learning around your life.

We believe learning should be an enjoyable, social experience, so our courses offer the opportunity to discuss what you’re learning with others as you go, helping you make fresh discoveries and form new ideas.
You can unlock new opportunities with unlimited access to hundreds of online short courses for a year by subscribing to our Unlimited package. Build your knowledge with top universities and organisations.

Learn more about how FutureLearn is transforming access to education